Cobaltous Sulfate is a pharmaceutical salt formed by ionic pairing of the active pharmacophore with a carefully selected counter-ion to optimise aqueous solubility, crystallinity, dissolution rate, and solid-state stability relative to the parent free form. Salt selection is a pivotal pharmaceutical development decision influencing polymorphic landscape, hygroscopicity, powder flow, compressibility, and bioavailability. Characterisation of Cobaltous Sulfate by XRPD, DSC, TGA, and dynamic vapour sorption is essential to define the approved solid-state form and ensure consistent quality across manufacturing batches.
Threshold of Toxicological Concern methodology provides a default PDE for Cobaltous Sulfate when conventional toxicological data are insufficient for NOAEL-based derivation. Cramer class assignment follows the decision-tree algorithm: Class I structures with simple chemistry lacking reactive functional groups carry a TTC of 1800 µg/day; Class II intermediate structures carry
